Novus Biologicals: Novus Therapeutics Reports Third Quarter 2018 Financial Results

Novus Therapeutics Inc. NASDAQ NVUS a specialty pharmaceutical company focused on developing products for patients with disorders of the ear nose and throat ENT today announced financial results for the quarter ended September 30 20...